469 related articles for article (PubMed ID: 21075313)
1. Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized.
Quintana E; Shackleton M; Foster HR; Fullen DR; Sabel MS; Johnson TM; Morrison SJ
Cancer Cell; 2010 Nov; 18(5):510-23. PubMed ID: 21075313
[TBL] [Abstract][Full Text] [Related]
2. Identification of cells initiating human melanomas.
Schatton T; Murphy GF; Frank NY; Yamaura K; Waaga-Gasser AM; Gasser M; Zhan Q; Jordan S; Duncan LM; Weishaupt C; Fuhlbrigge RC; Kupper TS; Sayegh MH; Frank MH
Nature; 2008 Jan; 451(7176):345-9. PubMed ID: 18202660
[TBL] [Abstract][Full Text] [Related]
3. CD271 is an imperfect marker for melanoma initiating cells.
Cheli Y; Bonnazi VF; Jacquel A; Allegra M; De Donatis GM; Bahadoran P; Bertolotto C; Ballotti R
Oncotarget; 2014 Jul; 5(14):5272-83. PubMed ID: 25105565
[TBL] [Abstract][Full Text] [Related]
4. Isolation of tumorigenic circulating melanoma cells.
Ma J; Lin JY; Alloo A; Wilson BJ; Schatton T; Zhan Q; Murphy GF; Waaga-Gasser AM; Gasser M; Stephen Hodi F; Frank NY; Frank MH
Biochem Biophys Res Commun; 2010 Nov; 402(4):711-7. PubMed ID: 20977885
[TBL] [Abstract][Full Text] [Related]
5. Human CD271-positive melanoma stem cells associated with metastasis establish tumor heterogeneity and long-term growth.
Civenni G; Walter A; Kobert N; Mihic-Probst D; Zipser M; Belloni B; Seifert B; Moch H; Dummer R; van den Broek M; Sommer L
Cancer Res; 2011 Apr; 71(8):3098-109. PubMed ID: 21393506
[TBL] [Abstract][Full Text] [Related]
6. Modulation of T-cell activation by malignant melanoma initiating cells.
Schatton T; Schütte U; Frank NY; Zhan Q; Hoerning A; Robles SC; Zhou J; Hodi FS; Spagnoli GC; Murphy GF; Frank MH
Cancer Res; 2010 Jan; 70(2):697-708. PubMed ID: 20068175
[TBL] [Abstract][Full Text] [Related]
7. CD271 Expression on Patient Melanoma Cells Is Unstable and Unlinked to Tumorigenicity.
Boyle SE; Fedele CG; Corbin V; Wybacz E; Szeto P; Lewin J; Young RJ; Wong A; Fuller R; Spillane J; Speakman D; Donahoe S; Pohl M; Gyorki D; Henderson MA; Johnstone RW; Papenfuss AT; Shackleton M
Cancer Res; 2016 Jul; 76(13):3965-77. PubMed ID: 27325642
[TBL] [Abstract][Full Text] [Related]
8. The human melanoma side population displays molecular and functional characteristics of enriched chemoresistance and tumorigenesis.
Wouters J; Stas M; Gremeaux L; Govaere O; Van den Broeck A; Maes H; Agostinis P; Roskams T; van den Oord JJ; Vankelecom H
PLoS One; 2013; 8(10):e76550. PubMed ID: 24098529
[TBL] [Abstract][Full Text] [Related]
9. CD133+ melanoma subpopulations contribute to perivascular niche morphogenesis and tumorigenicity through vasculogenic mimicry.
Lai CY; Schwartz BE; Hsu MY
Cancer Res; 2012 Oct; 72(19):5111-8. PubMed ID: 22865455
[TBL] [Abstract][Full Text] [Related]
10. Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271.
Boiko AD; Razorenova OV; van de Rijn M; Swetter SM; Johnson DL; Ly DP; Butler PD; Yang GP; Joshua B; Kaplan MJ; Longaker MT; Weissman IL
Nature; 2010 Jul; 466(7302):133-7. PubMed ID: 20596026
[TBL] [Abstract][Full Text] [Related]
11. Selection of tumorigenic melanoma cells using ALDH.
Boonyaratanakornkit JB; Yue L; Strachan LR; Scalapino KJ; LeBoit PE; Lu Y; Leong SP; Smith JE; Ghadially R
J Invest Dermatol; 2010 Dec; 130(12):2799-808. PubMed ID: 20739950
[TBL] [Abstract][Full Text] [Related]
12. Tumor stem cells (CD271, c-kit, SOX10) in Melanomas: prognostic and outcome implications.
Mohamed A; Gonzalez RS; Lawson D; Wang J; Cohen C
Appl Immunohistochem Mol Morphol; 2014; 22(2):142-5. PubMed ID: 23958542
[TBL] [Abstract][Full Text] [Related]
13. ABCB5 maintains melanoma-initiating cells through a proinflammatory cytokine signaling circuit.
Wilson BJ; Saab KR; Ma J; Schatton T; Pütz P; Zhan Q; Murphy GF; Gasser M; Waaga-Gasser AM; Frank NY; Frank MH
Cancer Res; 2014 Aug; 74(15):4196-207. PubMed ID: 24934811
[TBL] [Abstract][Full Text] [Related]
14. Tenascin-C promotes melanoma progression by maintaining the ABCB5-positive side population.
Fukunaga-Kalabis M; Martinez G; Nguyen TK; Kim D; Santiago-Walker A; Roesch A; Herlyn M
Oncogene; 2010 Nov; 29(46):6115-24. PubMed ID: 20729912
[TBL] [Abstract][Full Text] [Related]
15. Efficient tumour formation by single human melanoma cells.
Quintana E; Shackleton M; Sabel MS; Fullen DR; Johnson TM; Morrison SJ
Nature; 2008 Dec; 456(7222):593-8. PubMed ID: 19052619
[TBL] [Abstract][Full Text] [Related]
16. The helicase HAGE prevents interferon-α-induced PML expression in ABCB5+ malignant melanoma-initiating cells by promoting the expression of SOCS1.
Mathieu MG; Miles AK; Ahmad M; Buczek ME; Pockley AG; Rees RC; Regad T
Cell Death Dis; 2014 Feb; 5(2):e1061. PubMed ID: 24525737
[TBL] [Abstract][Full Text] [Related]
17. Potential for cripto-1 in defining stem cell-like characteristics in human malignant melanoma.
Strizzi L; Abbott DE; Salomon DS; Hendrix MJ
Cell Cycle; 2008 Jul; 7(13):1931-5. PubMed ID: 18604175
[TBL] [Abstract][Full Text] [Related]
18. Profiling of ABC transporters ABCB5, ABCF2 and nestin-positive stem cells in nevi, in situ and invasive melanoma.
Setia N; Abbas O; Sousa Y; Garb JL; Mahalingam M
Mod Pathol; 2012 Aug; 25(8):1169-75. PubMed ID: 22555176
[TBL] [Abstract][Full Text] [Related]
19. ABCB1 identifies a subpopulation of uveal melanoma cells with high metastatic propensity.
Landreville S; Agapova OA; Kneass ZT; Salesse C; Harbour JW
Pigment Cell Melanoma Res; 2011 Jun; 24(3):430-7. PubMed ID: 21575142
[TBL] [Abstract][Full Text] [Related]
20. Expression of SOX10, ABCB5 and CD271 in melanocytic lesions and correlation with survival data of patients with melanoma.
Gambichler T; Petig AL; Stockfleth E; Stücker M
Clin Exp Dermatol; 2016 Oct; 41(7):709-16. PubMed ID: 27663144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
